Aperio Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $5.77M | Buy |
|
|||||
|
2020
Q3 | $6.14M | Buy |
|
|||||
|
2020
Q2 | $5.75M | Buy |
|
|||||
|
2020
Q1 | $3.8M | Buy |
|
|||||
|
2019
Q4 | $3.74M | Buy |
|
|||||
|
2019
Q3 | $2.06M | Buy |
|
|||||
|
2019
Q2 | $1.68M | Sell |
|
|||||
|
2019
Q1 | $2.5M | Buy |
|
|||||
|
2018
Q4 | $1.5M | Sell |
|
|||||
|
2018
Q3 | $2.05M | Buy |
|
|||||
|
2018
Q2 | $2.04M | Sell |
|
|||||
|
2018
Q1 | $2.83M | Buy |
|
|||||
|
2017
Q4 | $2.68M | Buy |
|
|||||
|
2017
Q3 | $1.99M | Buy |
|
|||||
|
2017
Q2 | $1.28M | Buy |
|
|||||
|
2017
Q1 | $751K | Buy |
|
|||||
|
2016
Q4 | $319K | Sell |
|
|||||
|
2016
Q3 | $1.01M | Buy |
|
|||||
|
2016
Q2 | $654K | Sell |
|
|||||
|
2016
Q1 | $926K | Buy |
|
|||||
|
2015
Q4 | $604K | Buy |
|
|||||
|
2015
Q3 | $498K | Buy |
|
|||||
|
2015
Q2 | $669K | Buy |
|
|||||
|
2015
Q1 | $308K | Buy |
|
|||||
|
2014
Q4 | $283K | Buy |
|